{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-21-000179","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2021-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.078884+00:00","generated_at":"2026-06-30T06:48:20.265984+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NeoGenomics appoints Cardoza as President & COO, Lab Ops; Wallar as President, Pharma Services","bullets":["George A. Cardoza appointed President and COO, Lab Operations effective July 5, 2021; base salary $500k, bonus target 60%.","Dr. Gina M. Wallar appointed President, Pharma Services effective July 5, 2021; base salary $370k, bonus target 50%.","Cardoza awarded equity valued at $1M (7,584 restricted shares + option for 40,502 shares); Wallar awarded $250k equity.","Both appointments are internal promotions; Cardoza previously CFO and President Pharma Services, Wallar previously SVP Sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-21-000179","json":"https://secwatch.observer/filing/0001077183-21-000179.json","markdown":"https://secwatch.observer/filing/0001077183-21-000179.md","text":"https://secwatch.observer/filing/0001077183-21-000179.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/0001077183-21-000179-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/neo-20210705.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T06:48:20.265984+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"83bb9fdfa6","claim":"Gina M. Wallar was appointed as President, Pharma Services Division at NEOGENOMICS INC.","evidence_excerpt":"The Company announces that Dr. Gina M. Wallar, age 46, has been appointed President, Pharma Services Division effective July 5, 2021 to replace the vacancy left by Mr. Cardoza's assumption of his new position.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/0001077183-21-000179-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President, Pharma Services Division"}],"fact_type":"executive_change"},{"claim_id":"dd02e728aa","claim":"George A. Cardoza was appointed as President and Chief Operating Officer, Lab Operations at NEOGENOMICS INC.","evidence_excerpt":"NeoGenomics, Inc. (the “Company”) announces that George A. Cardoza, age 59, has been appointed President and Chief Operating Officer, Lab Operations effective July 5, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/0001077183-21-000179-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Operating Officer, Lab Operations"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}